CSNK2B modulates IRF1 binding to functional DNA elements and promotes basal and agonist-induced antiviral signaling.
Journal
Nucleic acids research
ISSN: 1362-4962
Titre abrégé: Nucleic Acids Res
Pays: England
ID NLM: 0411011
Informations de publication
Date de publication:
22 05 2023
22 05 2023
Historique:
accepted:
14
04
2023
revised:
21
03
2023
received:
05
12
2022
medline:
23
5
2023
pubmed:
24
4
2023
entrez:
24
04
2023
Statut:
ppublish
Résumé
Interferon regulatory factor 1 (IRF1) is a critical component of cell-intrinsic innate immunity that regulates both constitutive and induced antiviral defenses. Due to its short half-life, IRF1 function is generally considered to be regulated by its synthesis. However, how IRF1 activity is controlled post-translationally has remained poorly characterized. Here, we employed a proteomics approach to identify proteins interacting with IRF1, and found that CSNK2B, a regulatory subunit of casein kinase 2, interacts directly with IRF1 and constitutively modulates its transcriptional activity. Genome-wide CUT&RUN analysis of IRF1 binding loci revealed that CSNK2B acts generally to enhance the binding of IRF1 to chromatin, thereby enhancing transcription of key antiviral genes, such as PLAAT4 (also known as RARRES3/RIG1/TIG3). On the other hand, depleting CSNK2B triggered abnormal accumulation of IRF1 at AFAP1 loci, thereby down-regulating transcription of AFAP1, revealing contrary effects of CSNK2B on IRF1 binding at different loci. AFAP1 encodes an actin crosslinking factor that mediates Src activation. Importantly, CSNK2B was also found to mediate phosphorylation-dependent activation of AFAP1-Src signaling and exert suppressive effects against flaviviruses, including dengue virus. These findings reveal a previously unappreciated mode of IRF1 regulation and identify important effector genes mediating multiple cellular functions governed by CSNK2B and IRF1.
Identifiants
pubmed: 37094077
pii: 7137494
doi: 10.1093/nar/gkad298
pmc: PMC10201418
doi:
Substances chimiques
Chromatin
0
DNA
9007-49-2
Interferon Regulatory Factor-1
0
Casein Kinase II
EC 2.7.11.1
IRF1 protein, human
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
4451-4466Informations de copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of Nucleic Acids Research.
Références
J Virol. 2014 Feb;88(4):1897-913
pubmed: 24284321
Elife. 2017 Jan 16;6:
pubmed: 28079019
Nat Med. 2014 Aug;20(8):927-35
pubmed: 25064127
Biomed Res Int. 2015;2015:427814
pubmed: 26347881
Mol Cell Biol. 2004 Sep;24(17):7578-97
pubmed: 15314167
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
Mol Cell. 2010 May 28;38(4):576-89
pubmed: 20513432
Nat Rev Immunol. 2021 Mar;21(3):137-150
pubmed: 32782357
J Mol Signal. 2008 Jul 23;3:13
pubmed: 18651975
Front Pharmacol. 2015 Mar 31;6:70
pubmed: 25873900
Oncogene. 1998 Apr 30;16(17):2185-95
pubmed: 9619827
Mol Cell Biochem. 1999 Jan;191(1-2):169-80
pubmed: 10094406
J Exp Clin Cancer Res. 2019 Jul 5;38(1):287
pubmed: 31277672
Cell Chem Biol. 2022 May 19;29(5):799-810.e4
pubmed: 34520742
J Gen Virol. 2004 Jul;85(Pt 7):1801-1813
pubmed: 15218164
J Biol Chem. 2004 Dec 24;279(52):54793-801
pubmed: 15485829
Nucleic Acids Res. 2019 May 21;47(9):4476-4494
pubmed: 30854564
J Clin Invest. 2007 Oct;117(10):2962-73
pubmed: 17885682
Nucleic Acids Res. 2017 May 5;45(8):4743-4755
pubmed: 28082397
Sci Rep. 2018 Nov 9;8(1):16624
pubmed: 30413742
Bioinformatics. 2018 Sep 1;34(17):i884-i890
pubmed: 30423086
Nucleic Acids Res. 2016 Mar 18;44(5):e45
pubmed: 26578583
Cancer Res. 1996 Feb 1;56(3):612-5
pubmed: 8564980
ACS Pharmacol Transl Sci. 2020 Dec 11;4(1):206-212
pubmed: 33615173
J Mol Biol. 1999 Dec 17;294(5):1351-62
pubmed: 10600390
Nat Microbiol. 2019 Jul;4(7):1096-1104
pubmed: 30988429
Science. 1993 Feb 12;259(5097):968-71
pubmed: 8438156
Blood. 1996 Jul 1;88(1):114-23
pubmed: 8704165
Virol J. 2013 Apr 18;10:121
pubmed: 23597412
Signal Transduct Target Ther. 2021 May 17;6(1):183
pubmed: 33994545
Science. 2017 Aug 18;357(6352):
pubmed: 28818916
PLoS Pathog. 2021 Jan 21;17(1):e1009220
pubmed: 33476326
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Bioinformatics. 2015 Jul 15;31(14):2382-3
pubmed: 25765347
J Proteome Res. 2009 May;8(5):2551-62
pubmed: 19281230
Mol Cell Biol. 2014 Mar;34(6):1054-65
pubmed: 24396068
Front Oncol. 2020 Jun 18;10:893
pubmed: 32626654
Neoplasia. 2020 Oct;22(10):459-469
pubmed: 32784074
Exp Cell Res. 2009 Sep 10;315(15):2581-92
pubmed: 19540230
Science. 2016 Sep 30;353(6307):1541-1545
pubmed: 27633528
Nature. 2020 Jul;583(7816):459-468
pubmed: 32353859
Nucleic Acids Res. 1991 Aug 25;19(16):4421-8
pubmed: 1886766
Cell. 1994 Jun 17;77(6):829-39
pubmed: 8004672